The United States estimates it will begin vaccination against covid-19 in less than three weeks

“Our plan is to be able to deliver the vaccines to the immunization sites within 24 hours of approval. So I hope it starts on the second day after approval, which is December 11 or 12,” Moncef said. Slaoui in statements on CNN.

This high profile added that once this massive vaccination campaign is launched, the country is expected to achieve “collective immunity” in May.

“Usually, with the level of efficacy we have (95%), the fact that we immunize almost 70% of the population will allow us to have collective immunity. According to our studies, it should happen in May,” he said.

For Moncef Slaoui, the success of the campaign also depends on the social factor, as there is a suspicion about the vaccine.

“I hope it will reduce the negative perception of the vaccine and increase acceptance levels. It will be essential to help us,” he said.

Ten months after being able to isolate and sequence the novel coronavirus, pharmaceutical group Pfizer and BioNTech on Friday asked the United States Medicines Agency to authorize their vaccine against the disease caused by the new coronavirus.

This request was expected for several days, given that the result of the clinical trial conducted since July in more than 44,000 volunteers in different countries had been published, according to which the vaccine would be 95% effective in preventing covid-19, without effects. secondary.

The US agency announced that the Vaccine Advisory Committee meeting to review the request will be held on December 10.

The opinion of this committee is advisory. The decision whether or not to authorize the vaccine will be in the hands of scientists from the United States Medicines Agency. If there is a “green light”, the vaccine can be taken in the first half of December.

The government, still led by Donald Trump, plans to vaccinate 20 million people at risk in December and 25 to 30 million per month thereafter.

The United States is the country most affected by the disease by far. They crossed the 12 million case mark and recorded more than 255,000 deaths.